Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. AniCell Biotech, LLC
WARNING LETTER
•AniCell Biotech, LLC•September 13, 2017

AniCell Biotech, LLC – FDA Warning Letter, Sep 13, 2017

Record Details

On July 3, 2018, the FDA issued a Warning Letter to AniCell Biotech following an inspection from September 11-13, 2017, and a review of their website. The FDA determined that AniCell Biotech is marketing unapproved new animal drugs.

The company's cell-based, regenerative therapy products, including "CanisCell Treatments for Dogs," "CanisCell AniMatrix," and "CanisCell StemWrap," are intended for use in the mitigation, treatment, or prevention of disease in animals, classifying them as drugs under section 201(g)(1)(B) of the FD&C Act. Website statements indicated uses for orthopedic, bone, muscle, ligament, tendon, and eye issues, as well as wound management.

These products are considered "new animal drugs" under section 201(v) of the FD&C Act because they are not generally recognized as safe and effective by experts. Since they lack an approved new animal drug application, conditionally approved new animal drug application, or index listing under sections 512, 571, and 572 of the FD&C Act, they are deemed unsafe under section 512(a) and adulterated under section 501(a)(5) of the FD&C Act.

AniCell Biotech must notify the FDA in writing within fifteen working days of receipt of the letter,

Company
AniCell Biotech, LLC
Inspection date
September 13, 2017
Product type
Drugs
Office
Los Angeles District Office
Person
  • Steven E. Porter (Program Division Director)
View Company Profile

ID · 5dc7898b-077a-4cb1-8120-f319a086cb68

Violation Codes7
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(v)21 U.S.C. 360b21 U.S.C. 360ccc21 U.S.C. 360ccc-121 U.S.C. 360b(a)21 U.S.C. 351(a)(5)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AniCell Biotech, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.